SOAT1 and rheumatoid arthritis: Given the role played by the JAK/STAT pathway in inflammatory processes, considered together with the efficacy of methotrexate in treating rheumatoid arthritis-associated inflammation, our data suggests that suppression of JAK/STAT activation may represent the mechanism of action by which low-dose methotrexate moderates inflammatory conditions.